|
Frank R. Witney is currently President, CEO and a member of the Board of Directors of Panomics Inc. Panomics develops and markets products for single and multiplex gene and protein expression analysis from cell and tissue specimens, as well as cell-based assays. Dr. Witney is currently serving as a board member for Applied Precision, a privately held company that serves the semiconductor process and measurement systems and life science imaging market. Dr. Witney’s professional and academic interests have been focused on the biotech and life sciences market throughout his career. Prior to his current position, he was President of PerkinElmer’s Drug Discovery Business Unit and before that he served as President and COO of Packard BioSciences. | 